Oaktree Acquisition Corp. III Life Sciences (OACC)

Market Cap	258.12M
Revenue (ttm)	n/a
Net Income (ttm)	2.66M
Shares Out	24.58M
EPS (ttm)	n/a
PE Ratio	96.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	n/a
Previous Close	10.59
Day's Range	n/a
52-Week Range	9.95 - 10.85
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Oct 24, 2024
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: OACC

Financial Performance

Financial numbers in USD